These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28002389)

  • 1. Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
    Huaying S; Dong Y; Chihong Z; Xiaoqian Q; Danying W; Jianguo F
    Med Sci Monit; 2016 Dec; 22():5041-5048. PubMed ID: 28002389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential apoptotic effects of novel quinuclidinone analogs 8a and 8b in normal and lung cancer cell lines.
    Malki A; Bergmeier S
    Anticancer Res; 2011 Apr; 31(4):1345-57. PubMed ID: 21508385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
    Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
    Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
    Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
    Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
    Cuddihy AR; Jalali F; Coackley C; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints.
    Tao Y; Leteur C; Yang C; Zhang P; Castedo M; Pierré A; Golsteyn RM; Bourhis J; Kroemer G; Deutsch E
    Cell Cycle; 2009 Apr; 8(8):1196-205. PubMed ID: 19305158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression.
    Sanli T; Liu C; Rashid A; Hopmans SN; Tsiani E; Schultz C; Farrell T; Singh G; Wright J; Tsakiridis T
    J Thorac Oncol; 2011 Mar; 6(3):439-50. PubMed ID: 21258249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis.
    Cheng G; Kong D; Hou X; Liang B; He M; Liang N; Ma S; Liu X
    Cancer Biother Radiopharm; 2013 Mar; 28(2):153-9. PubMed ID: 23268708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation.
    Strnad P; Siegel M; Toivola DM; Choi K; Kosek JC; Khosla C; Omary MB
    FEBS Lett; 2006 Apr; 580(9):2351--2357. PubMed ID: 16616523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced radiosensitization of p53 mutant cells by oleamide.
    Lee YJ; Chung DY; Lee SJ; Ja Jhon G; Lee YS
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1466-74. PubMed ID: 16580498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane-induced apoptosis in Xuanwei lung adenocarcinoma cell line XWLC-05.
    Zhou L; Yao Q; Li Y; Huang YC; Jiang H; Wang CQ; Fan L
    Thorac Cancer; 2017 Jan; 8(1):16-25. PubMed ID: 27878984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of selected methylxanthine derivatives on radiosensitization of lung carcinoma cells.
    Malki AM; Gentry J; Evans SC
    Exp Oncol; 2006 Mar; 28(1):16-24. PubMed ID: 16614702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.
    Song M; Hwang H; Im CY; Kim SY
    J Med Chem; 2017 Jan; 60(2):554-567. PubMed ID: 28122456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
    Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
    Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.